Reducing anxiety and depression in OCD: a randomized controlled trial of exposure and response prevention therapy
Health Psychology Report · 03.03.2026
DOI: 10.5114/hpr/214074 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Health Psychology Report, online erschienen am 03.03.2026. Verfasst von Esmaeil Sadri Damirchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Background
Obsessive-compulsive disorder (OCD) frequently co-occurs with anxiety and depression, intensifying psychological distress and functional impairment. Although exposure and response prevention (ERP) is well established for treating core OCD symptoms, its effects on these common comorbid emotional disturbances remain underexplored. This study aimed to evalu-ate rigorously the effectiveness of ERP in reducing both anxiety and depressive symptoms in adults with OCD. Participants and procedure In a randomized controlled trial at Razi Clinic, Tabriz, Iran (April 2022–May 2023), 50 adults (18-60 years) meeting DSM-5 criteria for OCD were recruited and randomly assigned to either an ERP intervention group or a wait-list control group (n = 25 each). Both groups completed the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) at baseline and after intervention. The ERP group received eight weekly 90-minute sessions. Data were analyzed using analysis of covar-iance (ANCOVA), controlling for baseline scores.
Results
The ERP group demonstrated a significant reduction in anxiety scores, decreasing from 33.80 ± 4.15 to 24.24 ± 3.80 after treatment (p = .030), and in depression scores from 31.15 ± 3.20 to 17.44 ± 3.60 (p < .001). These improvements likely reflect ERP’s capacity to decrease avoidance behaviors and enhance emotion regulation.
Conclusions
ERP is an effective evidence-based intervention not only for OCD’s core symptoms but also for co-occurring anxiety and depression. Incorporating ERP into routine clinical practice may therefore yield broader emotional benefits for individuals with OCD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran.
- Department of Psychology, Bilesavar Branch, Islamic Azad University, Bilesavar, Iran.
ORCID-Profile: Esmaeil Sadri Damirchi, Saeed Pireinaladin
Zitieren
APA
Damirchi, E. S., Pireinaladin, S., & Mohammadzadeh, M. (2026). Reducing anxiety and depression in OCD: a randomized controlled trial of exposure and response prevention therapy. Health Psychology Report. https://doi.org/10.5114/hpr/214074
Vancouver
Damirchi ES, Pireinaladin S, Mohammadzadeh M. Reducing anxiety and depression in OCD: a randomized controlled trial of exposure and response prevention therapy. Health Psychology Report. 2026. doi:10.5114/hpr/214074
BibTeX
@article{Damirchi2026,
author = {Damirchi, Esmaeil Sadri and Pireinaladin, Saeed and Mohammadzadeh, Maryam},
title = {Reducing anxiety and depression in OCD: a randomized controlled trial of exposure and response prevention therapy},
journal = {Health Psychology Report},
year = {2026},
doi = {10.5114/hpr/214074}
}
EUVIMED